A stronger nicotine patch might break the dual Smoking-Vaping habit

NCT ID NCT07754578

First seen Aug 10, 2026 · Last updated Aug 12, 2026 · Updated 2 times

Summary

This trial tests whether higher doses of nicotine replacement therapy (NRT) can help adults who use both cigarettes and e-cigarettes quit both products. Participants are randomly assigned to receive either standard-dose NRT, augmented-dose NRT, or no NRT, with all groups getting behavioral support. The study measures whether people achieve biochemically confirmed abstinence from both products at 12 and 24 weeks, and also looks at DNA damage biomarkers related to tobacco use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Nicotine replacement therapy (nicotine patch and lozenge) at standard or augmented doses, plus behavioral support
What this could lead to
If successful, this could establish a more effective way to help people quit both cigarettes and e-cigarettes, potentially lowering cancer risk and improving long-term health.
What could go wrong
The trial is in Phase 2, so results are preliminary. Higher doses may cause more side effects, and quitting both products is challenging, so success rates may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER PREVENTION BEHAVIOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

nicotine dependence Smoking Vaping

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Medical University of South Carolina

    Charleston, South Carolina, 29425, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.